Karyopharm Therapeutics Inc. (KPTI) Social Stream



Karyopharm Therapeutics Inc. (KPTI): $2.24

0.02 (+0.90%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

B

Add KPTI to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#51 of 167

in industry

KARYOPHARM THERAPEUTICS INC (KPTI) Price Targets From Analysts

Use the tables below to see what analysts covering KARYOPHARM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $35 $6 $17.714 $2.5 608.56%
2021-11-19 8 $35 $6 $15.285 $2.5 511.4%
2021-12-21 8 $35 $6 $15.571 $2.5 522.84%
2022-02-01 8 $35 $8 $16 $2.5 540%
2022-02-09 8 $35 $8 $16.428 $2.5 557.12%
2022-03-02 8 $35 $6 $14.75 $2.5 490%
2022-03-18 8 $35 $6 $14.625 $2.5 485%
2022-04-12 7 $22 $6 $11.714 $2.5 368.56%
2022-05-06 7 $22 $6 $11.5 $2.5 360%
2022-07-14 7 $21 $5 $10.875 $2.5 335%
2022-08-04 9 $18 $5 $10.5 $2.5 320%
2022-08-05 8 $18 $5 $10.1 $2.5 304%
2022-10-20 8 $18 $5 $9.8 $2.5 292%
2022-11-04 9 $18 $5 $9.9 $2.5 296%
2022-12-13 9 $18 $5 $9.7 $2.5 288%
2023-01-10 9 $16 $5 $9.3 $2.5 272%
2023-01-19 10 $16 $5 $9.181 $2.5 267.24%
2023-02-15 9 $16 $5 $9 $2.5 260%
2023-03-30 10 $16 $5 $9.4 $2.5 276%
2023-04-19 10 $16 $5 $9.444 $2.5 277.76%
2023-05-04 10 $16 $5 $9 $2.5 260%
2023-05-08 10 $14 $5 $8.1 $2.5 224%

The Trend in the Analyst Price Target


Over the past 25 months, KPTI's average price target has gone down $22.3.

Over the past 49 weeks, KPTI's average upside potential has been 149.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-10 9 16 5 9.3 2.87 224.04%
2023-02-01 10 16 5 9.0 3.34 169.46%
2023-02-16 10 16 5 9.0 3.59 150.7%
2023-04-19 10 16 5 9.0 4.14 117.39%
2023-05-08 10 14 5 8.1 2.50 224%

KPTI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.9 5 1 4 0 0 10

The Trend in the Broker Recommendations


Over the past 16 months, KPTI's average broker recommendation rating improved by 0.6.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how KARYOPHARM THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2542.09% of that group.
  • In the context of all US stocks, KARYOPHARM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2528.42% of them.
  • KARYOPHARM THERAPEUTICS INC's number of analysts covering the stock is higher than 2600.51% of stocks in the small market cap category.
  • In the context of Healthcare stocks, KARYOPHARM THERAPEUTICS INC's average analyst price target is greater than 608.36% of them.

In the Pharmaceutical Products industry, ATOS, NHWK, and TVTX are the three stocks most similar to KARYOPHARM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding KPTI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8331 seconds.